Omnicell Drops Despite Q1 Earnings & Revs Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 8:20AM CDT
Omnicell, Inc. (OMCL) reported first-quarter 2014 adjusted EPS of 19 cents.
Omnicell Announces First Quarter 2014 Results
PR Newswire - Thu May 01, 3:00PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its first quarter ended March 31, 2014.
Omnicell Expands Unity Enterprise Platform to Enhance Workflow Efficiencies for Health System Enterprises
PR Newswire - Wed Apr 30, 12:03PM CDT
Omnicell, Inc., (NASDAQ: OMCL), today announced the availability of its expanded Unity enterprise platform, which will now include a central pharmacy inventory management system as part of the Company's 18.5 software release. The Unity enterprise platform is the premier medication and supply automation solution for use in a wide range of patient care venues throughout health care systems. Separately, with this software release, Omnicell announced the availability of advanced interoperability between its medication dispensing systems and the Cerner Millennium® electronic health record (EHR) via Cerner's CareAware iBus®.
Omnicell to Release First Quarter 2014 Earnings Results on May 1
PR Newswire - Thu Apr 24, 7:30AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, May 1, to discuss the Company's First Quarter 2014 financial results.
Omnicell Appoints Bruce Smith to Board of Directors
PR Newswire - Wed Apr 16, 7:00AM CDT
Omnicell, Inc., (NASDAQ: OMCL) today announced the appointment of Bruce D. Smith, senior vice president of information systems and CIO for Advocate Health Care, to its board of directors. With more than 25 years of health IT experience, Mr. Smith brings a unique understanding of the technology challenges facing today's hospitals and health systems.
Omnicell Up 14.0% Since SmarTrend Uptrend Call (OMCL)
Comtex SmarTrend(R) - Mon Apr 14, 9:58AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 5 months, Omnicell has returned 14.04% as of today's recent price of $27.46.
Upgrade Alert for Omnicell (OMCL)
Comtex SmarTrend(R) - Wed Apr 09, 7:57AM CDT
Omnicell (NASDAQ:OMCL) was upgraded from Hold to Buy at Craig-Hallum today. The stock closed yesterday at $27.64 on volume of 192,000 shares, below average daily volume of 238,000. Omnicell (NASDAQ:OMCL) has potential upside of 6.7% based on a current price of $27.64 and analysts' consensus price target of $29.50. The stock should hit resistance at its 50-day moving average (MA) of $28.03, as well as support at its 200-day MA of $24.44.
Omnicell Shares Up 13.5% Since SmarTrend's Buy Recommendation (OMCL)
Comtex SmarTrend(R) - Mon Apr 07, 9:21AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 5 months, Omnicell has returned 13.46% as of today's recent price of $27.32.
Omnicell Raised to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:38PM CDT
Over the past 60 days, Omnicell has been witnessing rising estimate revisions for 2014 with three upward revisions against no downward movement.
Omnicell Achieves International ISO Environmental Certification
PR Newswire - Tue Apr 01, 7:00AM CDT
Today Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare providers, announced it achieved certification for International Organization for Standardization (ISO) 14001:2004 Environmental Management System (EMS), demonstrating the company's commitment to lowering its environmental impact. The EMS is a framework that helps a company achieve its environmental goals through consistent control of its operations.
Cerner to Offer OTTR Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 6:00PM CDT
Currently, OTTR is the leading patient tracking application and patient record system specifically tailored for solid organ transplant centers and CERN will be the only electronic health record provider to offer it
15.1% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Fri Mar 28, 4:58PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 15.07% as of today's recent price of $27.71.
Patients Report Use of MTS Blister Card Improves Confidence in Safely Taking Medications and Reducing Emergency Room Visits
PR Newswire - Fri Mar 28, 7:18AM CDT
MTS, an Omnicell® Company and leading international provider of adherence packaging systems, today applauds the patient medication adherence research to be presented by Sharrel Pinto, BSPharm, DMM, MS, PhD, of the University of Toledo College of Pharmacy and Pharmaceutical Sciences at the American Pharmacists Association (APhA) 2014 Conference in Orlando. The research is the first to evaluate patient confidence in self administration of their medications between MTS RxMap®, an adherence blister card filled and sealed by the pharmacy, and self-organized pill vials, pillboxes, and medication pouches. The results showed that patients' confidence in taking their medications increased from 7% to 93% when using RxMap blister cards. Additionally, 36% of patients credited the blister card for playing a role in improving clinical results and helping reduce ER visits and hospitalizations.
Updated Research Report on Merge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:30AM CDT
On Mar 24, 2014, we issued an updated research report on Merge Healthcare.
Omnicell Has Returned 23.8% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Mar 21, 11:07AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 23.84% as of today's recent price of $29.82.
Uptrend Call Working As Omnicell Stock Rises 20.5% (OMCL)
Comtex SmarTrend(R) - Fri Mar 14, 9:44AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 20.53% as of today's recent price of $29.02.
Why Omnicell (OMCL) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:40AM CDT
Omnicell is well-positioned for future earnings growth and could be a strong growth stock contender
Shares of OMCL Up 19.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 07, 9:19AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 19.68% as of today's recent price of $28.82.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.